Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 99700
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99700
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99700
Table 1 The relationship between lupus nephritis and pregnancy
| Risk of lupus to pregnancy | Risk of pregnancy to lupus |
| Pregnancy loss | Lupus flares |
| Pre-term delivery | Progressive renal disease |
| Eclampsia | Maternal thromboembolism |
| Neonatal lupus due to Ro and La antibodies |
Table 2 Lupus nephritis in pregnancy: Evaluation and monitoring
| Before pregnancy | Every 6-8 weeks (adjustable)1 |
| Complete metabolic panel | Complete metabolic panel |
| Prothrombin time/partial thromboplastin time | |
| 24-h urinary protein and creatinine clearance2 | |
| sPCR | sPCR |
| Anti-dsDNA | Anti-dsDNA |
| Anti-Ro/SS-A and anti-La/SS-B antibodies | |
| Lupus anticoagulant3 | |
| Anticardiolipin IgG, IgM, IgA3 | |
| Anti-β2 glycoprotein I IgG, IgM, IgA3 | |
| Complement levels (C3, C4) | Complement levels (C3, C4) |
| Uric acid | Uric acid |
| Urine detailed report with microscopy | Urine detailed report with microscopy |
Table 3 Medication compatibility with pregnancy and lactation
| Medications | Before conception | During pregnancy | Lactation |
| Stop at conception | |||
| Abatacept | Stop with the positive pregnancy test | + | |
| Belimumab | Stop with the positive pregnancy test | + | |
| Rituximab | Stop with the positive pregnancy test | + | |
| Compatible drugs | |||
| Hydroxychloroquine | + | + | + |
| Azathioprine | + | + | + |
| Cyclosporine | + | + | + |
| Tacrolimus | + | + | + |
| Sulfasalazine | + | + | + |
| Prednisone | Dose < 20 mg/day | Dose < 20 mg/day | Dose < 20 mg/day |
| NSAIDs | Discontinue w/difficulty conceiving | Stop at week 20 | + |
| Non-compatible drugs | |||
| Cyclophosphamide | Stop 3 months before conception | x | x |
| MMF/mycophenolic acid | Stop 6 weeks before conception | x | x |
| Methotrexate | Stop 1-3 months before conception | x | x low transfer into breast milk |
Table 4 Features important in differentiating lupus nephritis from pre-eclampsia
| Features | Lupus nephritis | Pre-eclampsia |
| Timing | Any time during pregnancy | After 20 weeks of gestation |
| Hypertension | Can be present or absent | Always present |
| Other organ involvement | Present (e.g., skin, joints) | Absent |
| Complement levels (C3, C4) | Decreased or normal | Normal |
| Anti-dsDNA | Positive | Negative |
| Lupus serology | Active disease markers present | Usually absent |
| Active urinary sediment Urinary calcium Response to steroids | Present | Absent |
| > 195 mg/d | < 195 mg/d | |
| Generally responsive | No response | |
| Platelet count | Usually normal or mildly low | Often low (thrombocytopenia) |
| Liver enzymes | Usually normal | Elevated (HELLP syndrome) |
- Citation: Elahi T, Ahmed S, Mubarak M. Relationship of lupus nephritis and pregnancy: A narrative review. World J Nephrol 2024; 13(4): 99700
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/99700.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.99700
